Armistice Capital’s Moleculin Biotech MBRX Stock Holding History

Armistice Capital’s Portfolio MBRX Stock Details MBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$1.22M	Buy
2024 Q4	$540K	Buy
2024 Q3	$824K	Buy
2024 Q2	$549K	Buy
2024 Q1	$878K	Sell
2023 Q4	$2.75M	Buy
2019 Q2	–	Sell
2019 Q1	$179K	Buy